Clofazimine Prices, Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data Report 2025 Edition
Clofazimine Price Trend, Index and Forecast
Track the latest insights on clofazimine price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Clofazimine Prices Outlook Q3 2025
- USA: USD 776958/MT
- China: USD 500360/MT
- Germany: USD 725160/MT
- India: USD 543870/MT
- Brazil: USD 647465/MT
Clofazimine Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the clofazimine prices in the USA reached 776958 USD/MT in September. The price increase reflected stronger domestic demand from pharmaceutical manufacturers focusing on leprosy and multidrug-resistant tuberculosis treatments. Supply constraints due to raw material procurement delays and logistics bottlenecks contributed to upward pressure. Additionally, regulatory approvals for new formulations accelerated production investment, creating short-term supply shortages.
During the third quarter of 2025, the clofazimine prices in China reached 500360 USD/MT in September. Prices declined slightly due to moderate increases in domestic production capacity, which eased previous supply tightness. Competitive pressures among local manufacturers incentivized price moderation, particularly for bulk contracts. Raw material costs remained stable, preventing significant upward adjustments, while export demand softened amid international competition.
During the third quarter of 2025, the clofazimine prices in Germany reached 725160 USD/MT in September. The market experienced downward pressure as imports from neighboring European suppliers increased, providing additional availability. Domestic demand growth remained moderate, while manufacturers optimized production schedules to manage costs efficiently. Exchange rate fluctuations and stable raw material prices limited significant price adjustments.
During the third quarter of 2025, the clofazimine prices in India reached 543870 USD/MT in September. Prices increased notably due to rising domestic demand and inventory building by pharmaceutical companies. Limited availability of specific intermediates led to tighter supply conditions, contributing to upward pressure. Export demand from neighboring regions further reinforced price gains, while fluctuations in local manufacturing costs influenced quarterly adjustments.
During the third quarter of 2025, the clofazimine prices in Brazil reached 647465 USD/MT in September. Prices experienced a decline driven by the stabilization of imports and improved supply logistics. Domestic production expansion and favorable local raw material conditions eased prior shortages. Public procurement policies aimed at cost optimization also influenced pricing behavior. Moreover, reduced seasonal demand in the public healthcare segment moderated spot market activity. Currency stability further limited inflationary pressures on prices.
Clofazimine Prices Outlook Q2 2025
- USA: USD 760977/MT
- China: USD 509532/MT
- Germany: USD 741473/MT
- India: USD 527517/MT
- Brazil: USD 665431/MT
During the second quarter of 2025, the clofazimine prices in the USA reached 760977 USD/MT in June. The market reflected domestic demand from pharmaceutical manufacturers fulfilling treatment programs for leprosy and multidrug-resistant tuberculosis. Production adjustments and regulatory approvals for new distribution channels shaped supply schedules. Inventory replenishments and logistical planning influenced market activity, while manufacturers balanced procurement with anticipated seasonal requirements.
During the second quarter of 2025, the clofazimine prices in China reached 509532 USD/MT in June. Domestic manufacturing capacity and export demand determined supply allocations for institutional orders. Scheduling of production and raw material availability influenced the timing of deliveries. Local competition among manufacturers guided contract negotiations, and regional logistics improvements impacted product distribution.
During the second quarter of 2025, the clofazimine prices in Germany reached 741473 USD/MT in June. Market dynamics were shaped by import schedules and institutional procurement planning. Production and supply chain management focused on fulfilling demand across healthcare facilities. Regulatory monitoring ensured compliance and guided contract tendering processes.
During the second quarter of 2025, the clofazimine prices in India reached 527517 USD/MT in June. Manufacturing schedules and raw material procurement influenced product availability. Pharmaceutical companies coordinated inventories to align with regional distribution programs. Export activities and domestic demand planning determined resource allocation. Strategic stock management and operational adjustments influenced market behavior throughout the quarter.
During the second quarter of 2025, the clofazimine prices in Brazil reached 665431 USD/MT in June. Supply chain planning and import schedules shaped product availability. Procurement strategies by healthcare distributors guided inventory distribution. Seasonal healthcare program activities affected purchasing patterns. Production planning and raw material accessibility contributed to operational decision-making.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing clofazimine prices.
Europe Clofazimine Price Trend
Q3 2025:
The clofazimine price index in Europe reflected a moderate decrease, primarily due to higher imports from regional suppliers and stable raw material availability. Cost management initiatives by pharmaceutical manufacturers limited pricing pressure. Demand patterns remained steady, while regulatory oversight promoted competitive pricing. Overall, the European market demonstrated resilience amid stable regional supply and controlled demand dynamics.
Q2 2025:
In Europe, the clofazimine price index was shaped by a combination of import schedules, institutional procurement planning, and production capacity allocation. Suppliers coordinated deliveries to align with hospital and pharmaceutical program requirements, ensuring uninterrupted availability across multiple countries. Distribution logistics, including transportation routes and storage handling, influenced the timing of shipments and product accessibility in key markets. Raw material sourcing and allocation contributed to operational planning, guiding how manufacturers scheduled production runs.
This analysis can be extended to include detailed clofazimine price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Clofazimine Price Trend
Q3 2025:
The clofazimine price index in North America increased, driven by strong domestic demand and supply chain bottlenecks. Pharmaceutical inventory strategies contributed to higher spot market activity. Regulatory approvals and strategic stockpiling by manufacturers amplified short-term pricing pressures. Currency stability and logistics improvements supported consistent supply flow, reinforcing market strength throughout the quarter.
Q2 2025:
In North America, clofazimine pricing was influenced by domestic production scheduling, inventory management, and regulatory approvals for pharmaceutical operations. Manufacturers coordinated production runs with seasonal healthcare program requirements to ensure availability aligns with institutional demand. Inventory planning and distribution logistics guided the allocation of product across different states and facilities. Government procurement protocols and compliance regulations shaped operational decision-making, while strategic stock management supported uninterrupted supply.
Specific clofazimine historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Clofazimine Price Trend
Q3 2025:
As per the clofazimine price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the clofazimine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on clofazimine prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Clofazimine Price Trend
Q3 2025:
In the Asia Pacific, clofazimine prices reflected variation driven by differences in national production capacities and the intensity of export demand from neighboring regions. Countries with more advanced manufacturing infrastructure were able to maintain consistent output, while others faced scheduling adjustments to meet both domestic and international requirements. Supply chain considerations, including raw material sourcing, shipping timelines, and port congestion, influenced the timing and availability of shipments, moderating short-term price fluctuations.
Q2 2025:
In Asia Pacific, clofazimine pricing reflected the interaction of manufacturing schedules, distribution planning, and export considerations to meet regional demand requirements. Production cycles were coordinated with export commitments and domestic program needs. Inventory management strategies, including warehouse organization and stock rotation, guided resource allocation across countries. Government procurement initiatives played a role in determining supply priorities, while logistical adjustments addressed seasonal transport constraints and cross-border distribution requirements.
This clofazimine price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Clofazimine Price Trend
Q3 2025:
Clofazimine prices in Latin America reflected bearish sentiment resulting from improved import flows and stable production levels in key markets. Distribution networks were actively managed to align shipments with public healthcare program schedules, supporting efficient allocation of product across regional markets. Government procurement policies focused on cost-effectiveness influenced purchasing behavior, encouraging strategic inventory management by distributors and pharmaceutical companies.
Q2 2025:
Clofazimine prices in Latin America were influenced by import scheduling, production planning, and public sector procurement strategies. Distribution networks coordinated with government healthcare programs to ensure timely allocation across countries. Inventory management, including warehouse rotation and stock allocation, guided operational planning. Logistics coordination addressed transport challenges and optimized delivery timelines.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Clofazimine Pricing Report, Market Analysis, and News
IMARC's latest publication, “Clofazimine Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the clofazimine market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of clofazimine at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed clofazimine prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting clofazimine pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Clofazimine Industry Analysis
The global clofazimine market size reached USD 2.2 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 3.0 Billion, at a projected CAGR of 3.20% during 2026-2034. The market is primarily driven by the rising prevalence of multidrug-resistant tuberculosis, the expansion of public healthcare programs, and increasing investments in pharmaceutical manufacturing for essential antibiotics.
Latest News and Developments:
- February 2025: Recent studies explored human and bovine milk as vehicles to enhance drug solubilization and bioavailability. Oral administration in neonatal piglets and rodent models showed significant increases in plasma concentrations of up to 258% with human milk. These findings suggested milk-based formulations, particularly human milk, could safely improve clofazimine absorption in infants without additional excipients, offering a practical alternative to off-label formulations.
- April 2024: MannKind Corporation announced that the US Food and Drug Administration (FDA) cleared the company’s Investigational New Drug (IND) application for MNKD-101 (Clofazimine Inhalation Suspension), enabling the initiation of a Phase 3 study for the treatment of nontuberculous mycobacterial (NTM) lung disease.
Product Description
Clofazimine is a phenazine dye with antimycobacterial properties. It is utilized to treat leprosy and certain mycobacterial infections, including multi-drug-resistant tuberculosis. It binds to bacterial deoxyribonucleic acid (DNA), disrupting replication and leading to bacterial death. It is a lipophilic compound with strong anti-inflammatory attributes and is available in oral capsule form, composed of clofazimine, gelatin, and other excipients. It finds application in the treatment of leprosy, multi-drug-resistant tuberculosis, Mycobacterium avium complex, Crohn's disease, Buruli ulcer, lupus, severe acne, erythrasma, and coronavirus (COVID-19).
The drug offers several benefits, such as effectiveness against resistant bacterial strains, a long half-life, reduced inflammation, a low likelihood of resistance development, minimal drug interactions, convenient oral administration, improved quality of life, cost-effectiveness, and suitability for long-term therapy. Moreover, it is lauded for its high efficacy, versatile therapeutic uses, prolonged antibacterial effect, anti-inflammatory properties, low resistance profile, and compatibility.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Clofazimine |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Clofazimine Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of clofazimine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting clofazimine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The clofazimine price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.